Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Discovery of compound could enhance cancer treatments with fewer side effects

21.12.2004


The discovery of a new compound by Michigan State University researchers could lead to improved chemotherapy treatments for different types of cancers – potentially with fewer side effects.

The discovery of the compound – known as SP-4-84 – was made by an MSU team led by Jetze Tepe, an assistant professor of chemistry, and is detailed in the December issue of the journal Chemistry & Biology. The researchers believe that the compound, when used in conjunction with chemotherapy drugs such as cisplatin and camptothecin, can make the anti-cancer drugs much more effective. “This may potentially mean that one could use less than one-tenth of the current drug dosage and still get the same therapeutic results – but fewer side effects – or use the same drug dosage which is now much more effective in its treatment,” Tepe said.

Even though this new compound is in the earliest stage of development, this is potentially good news for the millions of Americans diagnosed with cancer every year. The national Centers for Disease Control and Prevention says more than a half-million Americans die of cancer every year, second only to heart disease. Here is how the newly discovered compound works: Most anti-cancer drugs work by causing cell damage, such as DNA damage, which ultimately kills the cancer cells. However, cancer cells are also prone to repair themselves and survive the damage done by drugs, which renders the drugs less effective.



Tepe and his colleagues found that when SP-4-84 was added to certain anti-cancer drugs, it inhibited the cancer cell’s ability to survive chemotherapeutic treatment. “Essentially,” he said, “it sensitizes only cancer cells to chemotherapeutics by blocking the cancer cell’s ability to survive the damage that was caused by the chemotherapeutic drugs.”

Another problem with chemotherapy drugs is that they generally don’t discriminate between cancer cells and healthy cells. The drugs basically damage all cells that are continuing to replicate. “So, if we’re able to give the patient a drug that remains as effective despite a smaller dose, this could spare the patient a lot of side effects such as severe nausea, kidney or liver damage, and other side effects typically experienced during chemotherapy,” Tepe said.

“Tests preformed with cancer cells in culture found that over a 48-hour period small amounts of SP-4-84 made camptothecin 75 times more effective that conventional treatment,” he said. “However, when we used the compound on non-cancerous cells, there was absolutely no effect. It appears right now that the compound is only selective for cancer cells.” Thus far, SP-4-84 appears to be extremely non-toxic, he said.

In their current work, Tepe and his co-workers have teamed up with MSU’s Carcinogenesis Laboratory, where the teams are evaluating the new compound in mice. "As with all new discoveries, much more work needs to be done to evaluate the potential of this compound for its ability to improve conventional therapeutic treatment,” Tepe said.

Other members of Tepe’s team include graduate students Vasudha Sharma and Satyamaheshwar Peddibhotla, and research associate Theresa Lansdell.

Tom Oswald | EurekAlert!
Further information:
http://www.msu.edu

More articles from Life Sciences:

nachricht Multi-institutional collaboration uncovers how molecular machines assemble
02.12.2016 | Salk Institute

nachricht Fertilized egg cells trigger and monitor loss of sperm’s epigenetic memory
02.12.2016 | IMBA - Institut für Molekulare Biotechnologie der Österreichischen Akademie der Wissenschaften GmbH

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

Im Focus: Fraunhofer ISE Develops Highly Compact, High Frequency DC/DC Converter for Aviation

The efficiency of power electronic systems is not solely dependent on electrical efficiency but also on weight, for example, in mobile systems. When the weight of relevant components and devices in airplanes, for instance, is reduced, fuel savings can be achieved and correspondingly greenhouse gas emissions decreased. New materials and components based on gallium nitride (GaN) can help to reduce weight and increase the efficiency. With these new materials, power electronic switches can be operated at higher switching frequency, resulting in higher power density and lower material costs.

Researchers at the Fraunhofer Institute for Solar Energy Systems ISE together with partners have investigated how these materials can be used to make power...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

UTSA study describes new minimally invasive device to treat cancer and other illnesses

02.12.2016 | Medical Engineering

Plasma-zapping process could yield trans fat-free soybean oil product

02.12.2016 | Agricultural and Forestry Science

What do Netflix, Google and planetary systems have in common?

02.12.2016 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>